Arun Pattabhiraman, Sprinklr, Inc. (NYSE:CXM) Chief Marketing Officer, executed a sale of 32,500 shares of Class A common stock on March 16, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The shares moved at a weighted average price of $5.85, producing total proceeds of $190,125.
The disposition was carried out across multiple trades with execution prices spanning $5.765 to $5.91, inclusive. Sprinklr indicated the sale was the result of the company election under its equity incentive plans to satisfy statutory tax withholding obligations arising from the vesting of restricted stock units, and was not a discretionary sale by the officer.
After the transaction, Pattabhiraman is listed as directly holding 485,378 shares of Sprinklr Class A common stock.
Market context in the filing notes that CXM was trading at $5.98, reflecting a 27% decline over the prior six months and trading near a 52-week low of $5.12.
Separately, company results for fiscal fourth-quarter 2026 showed an earnings per share of $0.13, ahead of a consensus forecast of $0.09. Revenue for the quarter reached $220.6 million, topping an anticipated $215.51 million. Those results were cited as evidence of solid near-term operational performance.
Analyst reactions have been mixed. Citizens retained a Market Outperform rating but lowered its price target from $17.00 to $11.00, noting that Sprinklr said its three-phase transformation is taking longer than initially expected, and it does not foresee a material reacceleration in growth before fiscal year 2028. DA Davidson trimmed its price objective to $6.50 from $9.00 and maintained a Neutral rating, pointing out that although revenue and profitability exceeded expectations, the company guidance for fiscal 2027 was below consensus estimates.
Additional market commentary referenced an InvestingPro analysis that characterizes Sprinklr as appearing undervalued at current price levels and highlights the company holds a stronger cash position than debt on the balance sheet. The platform review also mentions supplementary ProTips and financial health metrics, along with Pro Research Reports covering over 1,400 U.S. equities.
Note on sourcing: All transaction details are reported as filed in the Form 4 disclosure and are presented here without commentary beyond the facts contained in those filings and cited analyst comments.